120 related articles for article (PubMed ID: 16333392)
1. [Hepatotoxicity caused by antituberculosis drugs in pediatrics].
Reto Valiente LV; Castillo Vergara J; Pichilingue Reto P; Pichilingue Prieto OA
Rev Gastroenterol Peru; 2005; 25(4):362-5. PubMed ID: 16333392
[TBL] [Abstract][Full Text] [Related]
2. Monitoring and management of antituberculosis drug induced hepatotoxicity.
Agal S; Baijal R; Pramanik S; Patel N; Gupte P; Kamani P; Amarapurkar D
J Gastroenterol Hepatol; 2005 Nov; 20(11):1745-52. PubMed ID: 16246196
[TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity due to antituberculosis therapy. Clinical profile and reintroduction of therapy.
Singh J; Garg PK; Tandon RK
J Clin Gastroenterol; 1996 Apr; 22(3):211-4. PubMed ID: 8724260
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients.
Ohkawa K; Hashiguchi M; Ohno K; Kiuchi C; Takahashi S; Kondo S; Echizen H; Ogata H
Clin Pharmacol Ther; 2002 Aug; 72(2):220-6. PubMed ID: 12189369
[TBL] [Abstract][Full Text] [Related]
5. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
[TBL] [Abstract][Full Text] [Related]
6. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus.
Ungo JR; Jones D; Ashkin D; Hollender ES; Bernstein D; Albanese AP; Pitchenik AE
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1871-6. PubMed ID: 9620920
[TBL] [Abstract][Full Text] [Related]
7. [Hepatotoxicity of antitubercular drugs. Apropos of 28 cases].
Sakhri A; Ben Kemla S; Khadraoui M; Cheikh R
Tunis Med; 2003 Jul; 81(7):488-94. PubMed ID: 14534960
[TBL] [Abstract][Full Text] [Related]
8. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
[TBL] [Abstract][Full Text] [Related]
9. Antituberculosis drugs and hepatotoxicity.
Yew WW; Leung CC
Respirology; 2006 Nov; 11(6):699-707. PubMed ID: 17052297
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced hepatotoxicity and tuberculosis in a hospital from the Argentinian northeast: cross-sectional study.
Golemba AS; Ferreyra FG; Martearena RE; Achinelli FR; Rovai GB
Medwave; 2015 May; 15(4):e6135. PubMed ID: 26035138
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of patient-related factors associated with causality, preventability, predictability and severity of hepatotoxicity during antituberculosis [correction of antituberclosis] treatment.
Sharifzadeh M; Rasoulinejad M; Valipour F; Nouraie M; Vaziri S
Pharmacol Res; 2005 Apr; 51(4):353-8. PubMed ID: 15683749
[TBL] [Abstract][Full Text] [Related]
12. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.
Shakya R; Rao BS; Shrestha B
Ann Pharmacother; 2004 Jun; 38(6):1074-9. PubMed ID: 15122004
[TBL] [Abstract][Full Text] [Related]
13. Management of antitubercular drugs-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal.
Shakya R; Rao BS; Shrestha B
Kathmandu Univ Med J (KUMJ); 2005; 3(1):45-9. PubMed ID: 16401944
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicity Due to Antituberculosis Therapy among Paediatric Patients Seen at the University of Ilorin Teaching Hospital, North Central Nigeria.
Aishatu G; Rasheedah I; Wahab J; Sheni M; Damilola O; Adeniyi O
Ethiop J Health Sci; 2017 Mar; 27(2):115-120. PubMed ID: 28579706
[TBL] [Abstract][Full Text] [Related]
15. Antituberculosis drug-induced hepatitis: risk factors, prevention and management.
Hussain Z; Kar P; Husain SA
Indian J Exp Biol; 2003 Nov; 41(11):1226-32. PubMed ID: 15332488
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxicity and antituberculosis therapy: time to revise UK guidance?
Walker NF; Kliner M; Turner D; Bhagani S; Cropley I; Hopkins S; Lipman M
Thorax; 2009 Oct; 64(10):918. PubMed ID: 19786720
[No Abstract] [Full Text] [Related]
17. The management of anti-tuberculosis drug-induced hepatotoxicity.
Tahaoğlu K; Ataç G; Sevim T; Tärün T; Yazicioğlu O; Horzum G; Gemci I; Ongel A; Kapakli N; Aksoy E
Int J Tuberc Lung Dis; 2001 Jan; 5(1):65-9. PubMed ID: 11263519
[TBL] [Abstract][Full Text] [Related]
18. [Severe hepatotoxicity of tuberculostatic agents. Increase in the incidence].
Moitinho E; Salmerón JM; Mas A; Bruguera M; Rodés J
Gastroenterol Hepatol; 1996 Nov; 19(9):448-51. PubMed ID: 8998667
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity to different antituberculosis drug combinations.
Aziz S; Agha F; Hassan R; Fairoz SA; Hassan K
J Pak Med Assoc; 1990 Dec; 40(12):290-4. PubMed ID: 2126569
[TBL] [Abstract][Full Text] [Related]
20. [A study of 172 patients with hepatic injury caused by antituberculosis drugs].
Cheng SQ
Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):571. PubMed ID: 15387923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
